MEDAVAIL HLDGS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MDVLQ and buy or sell other stocks, ETFs, and their options commission-free!

About MDVLQ

MedAvail Holdings, Inc. is a pharmacy technology and services company, which engages in the development and commercialization of a self-service pharmacy, mobile application, and kiosk. It operates through the Retail Pharmacy Services and Pharmacy Technology segments. 

CEO
Mark Doerr
CEOMark Doerr
Employees
279
Employees279
Headquarters
Phoenix, Arizona
HeadquartersPhoenix, Arizona
Founded
2007
Founded2007
Employees
279
Employees279

MDVLQ Key Statistics

Market cap
161.39
Market cap161.39
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
26.50
Average volume26.50
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

MEDAVAIL HLDGS INC(MDVLQ) stock is priced at $0.00, giving the company a market capitalization of 161.39.

During the trading day, MEDAVAIL HLDGS INC(MDVLQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for MEDAVAIL HLDGS INC(MDVLQ) stock has reached 0, versus its average volume of 26.5.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

The stock's 52-week range extends from a low of $0.00 to a high of $0.05.

People also own

Based on the portfolios of people who own MDVLQ. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.